Individual estimates of age at detectable amyloid onset for risk factor assessment-Reference-Cited by-同舟云学术

Individual estimates of age at detectable amyloid onset for risk factor assessment

Published:2015-11-14 Issue:4 Volume:12 Page:373-379
ISSN:1552-5260
Container-title:Alzheimer's & Dementia
language:en
Short-container-title:Alzheimer's & Dementia

Author:

Bilgel Murat¹²,An Yang¹,Zhou Yun³,Wong Dean F.³,Prince Jerry L.²³⁴,Ferrucci Luigi⁵,Resnick Susan M.¹

Affiliation:

1. Laboratory of Behavioral Neuroscience, Intramural Research Program National Institute on Aging Baltimore MD USA

2. Department of Biomedical Engineering Johns Hopkins University Baltimore MD USA

3. Department of Radiology Johns Hopkins Medical Institutions Baltimore MD USA

4. Department of Electrical and Computer Engineering Johns Hopkins University Baltimore MD USA

5. Translational Gerontology Branch, Intramural Research Program National Institute on Aging Baltimore MD USA

Funder

National Institute on Aging

National Institutes of Health

Publisher

Wiley

Subject

Psychiatry and Mental health,Cellular and Molecular Neuroscience,Geriatrics and Gerontology,Neurology (clinical),Developmental Neuroscience,Health Policy,Epidemiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1016/j.jalz.2015.08.166

Reference43 articles.

1. Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

2. Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study

3. The role of APOE polymorphisms in late-onset dementias

4. Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy

5. Amyloid-beta plaque growth in cognitively normal adults: Longitudinal [11C]Pittsburgh compound B data

Cited by 65 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Explainable artificial intelligence identifies an AQP4 polymorphism-based risk score associated with brain amyloid burden;Neurobiology of Aging;2024-11

2. Proteome-wide analysis identifies plasma immune regulators of amyloid-beta progression;Brain, Behavior, and Immunity;2024-08

3. Predicting amyloid‐PET and clinical conversion in apolipoprotein E ε3/ε3 non‐demented individuals with multidimensional factors;European Journal of Neuroscience;2024-05-02

4. Characterizing brain tau and cognitive decline along the amyloid timeline in Alzheimer’s disease;Brain;2024-04-26

5. New precision medicine avenues to the prevention of Alzheimer’s disease from insights into the structure and function of γ-secretases;The EMBO Journal;2024-02-23